53 results on '"Bauser-Heaton H"'
Search Results
2. Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory.
- Author
-
Bauser-Heaton H, Barry OM, Hofferberth SC, Tretter JT, Ma M, Goldstone A, Armstrong A, Jones TK, Yoganathan A, and Del Nido P
- Abstract
The Heart Valve Collaboratory is a multidisciplinary, patient-centered community of stakeholders addressing complex problems and embracing innovation to help patients with heart valve disease achieve their fullest potential for health. The Scientific Council is composed of cardiologists, surgeons, ex-officio representatives of the Food and Drug Administration and Centers for Medicare and Medicaid Services, National Heart Lung Blood Institute, and representatives from industry partners. In October 2022, this group convened a workshop that included experts from stakeholder groups to address the unmet and clinical needs of patients with pediatric and congenital heart valve disease. The following document includes the discussion and summary of the current state of valve therapy and the needs being addressed for valve development., Competing Interests: Dr Hofferberth is an employee, board member, and equity holder for Autus Valve Technologies, Inc. Dr Tretter is a consultant for Cara Medical Ltd. Dr Armstrong is a consultant for Medtronic and Edwards Lifesciences. Dr Jones is an investigator, consultant, and proctor for Medtronic; and has received research support and is a consultant for Edwards Lifesciences. Dr Nido is a consultant for Autus Valve Technologies, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (© 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation.)
- Published
- 2024
- Full Text
- View/download PDF
3. FSTL-1 loaded 3D bioprinted vascular patch regenerates the ischemic heart tissue.
- Author
-
Hwang B, Korsnick L, Shen M, Jin L, Singh Y, Abdalla M, Bauser-Heaton H, and Serpooshan V
- Abstract
Cardiac patch strategies are developed as a promising approach to regenerate the injured heart after myocardial infarction (MI). This study integrated 3D bioprinting and cardioprotective paracrine signaling to fabricate vascular patch devices containing endothelial cells (ECs) and the regenerative follistatin-like 1 (FSTL1) peptide. Engineered patch supported the 3D culture of ECs in both static and dynamic culture, forming a uniform endothelium on the printed channels. Implantation of vascular patch onto a rat model of acute MI resulted in significant reduction of scar formation, left ventricle dilation, and wall thinning, as well as enhanced ejection fraction. Furthermore, increased vascularization and proliferation of cardiomyocytes were observed in hearts treated with patches. These findings highlight the remarkable capacity of 3D bioprinted vascular patch to augment the endogenous regenerative capacity of mammalian heart, together with the exogenous cardioprotective function, to serve as a robust therapeutic device to treat acute MI., Competing Interests: V.S. is an inventor on a patent describing a cast collagen patch to deliver FSTL1 for the treatment of myocardial infarction (US Patent 14,168,826). Vahid Serpooshan is a consulting academic editor at iScience and serves as one of the Guest Editors of the Special Issue “Advanced biomanufacturing of cardiovascular tissues”., (© 2024 Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
4. Mind the Gap! Working Toward Gender Equity in Pediatric and Congenital Heart Disease: Present and Future.
- Author
-
Chowdhury D, Bansal N, Ansong A, Baker Smith C, Bauser-Heaton H, Choueiter N, Co-Vu J, Elliott P B.S, Fuller S, Jain SS, Jone PN, Johnson JN, Karamlou T, Kipps AK, Laraja K, Lopez KN, Rasheed M, Ronai C, Sachdeva R, Saidi A, Snyder C, Sutton N, Stiver C, Taggart NW, Shaffer K, and Williams R
- Subjects
- Humans, Female, Male, Leadership, Cardiology trends, Pediatrics trends, Salaries and Fringe Benefits, Sexism trends, Sex Factors, Cardiologists trends, Heart Defects, Congenital epidemiology, Heart Defects, Congenital therapy, Gender Equity, Physicians, Women statistics & numerical data, Physicians, Women trends
- Abstract
Evidence from medicine and other fields has shown that gender diversity results in better decision making and outcomes. The incoming workforce of congenital heart specialists (especially in pediatric cardiology) appears to be more gender balanced, but past studies have shown many inequities. Gender-associated differences in leadership positions, opportunities presented for academic advancement, and recognition for academic contributions to the field persist. In addition, compensation packages remain disparate if evaluated based on gender with equivalent experience and expertise. This review explores these inequities and has suggested individual and institutional changes that could be made to recruit and retain women, monitor the climate of the institution, and identify and eliminate bias in areas like salary and promotions.
- Published
- 2024
- Full Text
- View/download PDF
5. Collaboration in the Interventional Care of the Adult Congenital Heart Disease Patient: Teamwork Is Key.
- Author
-
Bauser-Heaton H, Fagan TE, Ing FF, Kavinsky CJ, Zablah JE, Armstrong AK, Gerard R, Khanna R, LeVasseur M, Tinberg N, and Vanderford K
- Published
- 2023
- Full Text
- View/download PDF
6. Durable Vascular Access in Neonates in the Cardiac ICU: A Novel Technique for Tunneled Femoral Central Venous Catheters.
- Author
-
Mills M, Chanani N, Wolf M, Bauser-Heaton H, Beshish A, Aljiffry A, Zinyandu T, and Maher K
- Subjects
- Infant, Newborn, Humans, Child, Retrospective Studies, Intensive Care Units, Pediatric, Central Venous Catheters, Catheterization, Central Venous methods, Thrombosis, Catheter-Related Infections epidemiology
- Abstract
Objectives: There is an ongoing need for a method of obtaining long-term venous access in critically ill pediatric patients that can be completed at the bedside and results in a durable, highly functional device. We designed a novel technique for tunneled femoral access to address this need. Herein, we describe the procedure and review the outcomes at our institution., Design: A single-center retrospective chart review identifying patients who underwent tunneled femoral central venous catheter (tfCVC) placement between 2017 and 2021 using a two-puncture technique developed by our team., Setting: Academic, Quaternary Children's Hospital with a dedicated pediatric cardiac ICU (CICU)., Patients: Patients in our pediatric CICU who underwent this procedure., Interventions: Tunneled femoral central line placement., Measurements and Main Results: One hundred eighty-two encounters were identified in 161 patients. The median age and weight at the time of catheter placement was 22 days and 3.2 kg. The median duration of the line was 22 days. The central line-associated bloodstream infection (CLABSI) rate was 0.75 per 1,000-line days. The prevalence rate of thrombi necessitating pharmacologic treatment was 2.0 thrombi per 1,000-line days. There was no significant difference in CLABSI rate per 1,000-line days between the tfCVC and nontunneled peripherally inserted central catheters placed over the same period in a similar population (-0.40 [95% CI, -1.61 to 0.82; p = 0.52]) and no difference in thrombus rates per 1,000-line days (1.37 [95% CI, -0.15 to 2.89; p = 0.081])., Conclusions: tfCVCs can be placed by the intensivist team using a two-puncture technique at the bedside with a high-rate of procedural success and low rate of complications. Advantages of this novel technique of obtaining vascular access include a low rate of CLABSIs, the ability to place it at the bedside, and preservation of the upper extremity vasculature., Competing Interests: Dr. Bauser-Heaton received a grant from the American Heart Association; she disclosed that she is Proctor for Gore. The remaining authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.)
- Published
- 2023
- Full Text
- View/download PDF
7. Comparison of treatment strategies for neonates with tetralogy of Fallot and pulmonary atresia.
- Author
-
Meadows JJ, Bauser-Heaton H, Petit CJ, Goldstein BH, Qureshi AM, McCracken CE, Kelleman MS, Nicholson GT, Law MA, Zampi JD, Shahanavaz S, Chai PJ, Romano JC, Batlivala SP, Maskatia SA, Asztalos IB, Eilers L, Kamsheh AM, Healan SJ, Smith JD, Ligon RA, Dailey-Schwartz A, Pettus JA, Pajk AL, Glatz AC, and Mascio CE
- Subjects
- Infant, Newborn, Humans, Infant, Retrospective Studies, Aorta, Pulmonary Artery surgery, Treatment Outcome, Tetralogy of Fallot, Pulmonary Atresia surgery, Pulmonary Atresia complications, DiGeorge Syndrome
- Abstract
Objective: Neonates with tetralogy of Fallot and pulmonary atresia (TOF/PA) but no major aorta-pulmonary collaterals are dependent on the arterial duct for pulmonary blood flow and require early intervention, either by primary (PR) or staged repair (SR) with initial palliation (IP) followed by complete repair (CR). The optimal approach has not been established., Methods: Neonates with TOF/PA who underwent PR or SR were retrospectively reviewed from the Congenital Cardiac Research Collaborative. Outcomes were compared between PR and SR (IP + CR) strategies. Propensity scoring was used to adjust for baseline differences. The primary outcome was mortality. Secondary outcomes included complications, length of stay, cardiopulmonary bypass and anesthesia times, reintervention (RI), and pulmonary artery (PA) growth., Results: Of 282 neonates, 106 underwent PR and 176 underwent SR (IP: 144 surgical, 32 transcatheter). Patients who underwent SR were more likely to have DiGeorge syndrome and greater rates of mechanical ventilation before the initial intervention. Mortality was not significantly different. Duration of mechanical ventilation, inotrope use, and complication rates were similar. Cumulative length of stay, cardiopulmonary bypass, and anesthesia times favored PR (P ≤ .001). Early RI was more common in patients who underwent SR (rate ratio, 1.42; P = .003) but was similar after CR (P = .837). Conduit size at the time of CR was larger with SR. Right PA growth was greater with PR., Conclusions: In neonates with TOF/PA, SR is more common in greater-risk patients. Accounting for this, SR and PR strategies have similar mortality. Perioperative morbidities, RI, and right PA growth generally favor PR, whereas SR allows for larger initial conduit implantation., (Copyright © 2023 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
8. Erratum: Stenting of the Patent Ductus Arteriosus: A Meta-analysis and Literature Review.
- Author
-
Bauser-Heaton H, Price K, Weber R, and El-Said H
- Abstract
[This corrects the article DOI: 10.1016/j.jscai.2022.100392.][This corrects the article DOI: 10.1016/j.jscai.2023.101051.]., (© 2022 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
9. Outcomes Following Balloon Pulmonary Valvuloplasty in Symptomatic Neonates With Tetralogy of Fallot-A CCRC Study.
- Author
-
Shahanavaz S, Qureshi AM, Petit CJ, Goldstein BH, Glatz AC, Bauser-Heaton H, McCracken CE, Kelleman MS, Nicholson GT, Zampi JD, Pettus J, Meadows J, Hock KM, and Law MA
- Abstract
Background: Complete repair (CR) can be delayed in neonates with symptomatic tetralogy of Fallot (sTOF) using surgical or transcatheter palliation to relieve cyanosis. Balloon pulmonary valvuloplasty (BPV) is an established treatment for pulmonary valve stenosis; however, its effectiveness in palliating neonates with sTOF has not been well investigated., Methods: A retrospective chart review between 2005 and 2017 on neonates with sTOF who underwent initial BPV from 9 participating centers of the Congenital Cardiac Research Collaborative was performed. Primary outcome was CR at >30 days after BPV without interval reintervention (RI)., Results: In total, 47 neonates with sTOF underwent BPV, of whom 27 (57%) underwent CR at >30 days after BPV without RI. The median time to CR was 151 days (106-210). RI before CR occurred in 17 patients (36%): surgical shunt (n = 7), outflow tract stenting (n = 6), patent ductus arteriosus stenting (n = 2), and surgical outflow patch (n = 2). Valve-sparing repair at CR was performed in 6 patients (13%) after initial BPV. RI or CR ≤30 days from BPV was associated with smaller infundibular diastolic diameter ( P = .004). An infundibular diastolic diameter of <3.4 mm demonstrated 75% sensitivity and 67% specificity to predict early CR or RI., Conclusions: BPV can be an effective palliative therapy in select neonates with sTOF to delay CR. A smaller diastolic infundibulum diameter is a predictor of RI or early CR, and valve-sparing repair is uncommon, making patient selection and alternative palliative methods key when considering BPV palliation in neonates with sTOF., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
10. Extrusion-Based 3D Bioprinting of Adhesive Tissue Engineering Scaffolds Using Hybrid Functionalized Hydrogel Bioinks.
- Author
-
Chen S, Tomov ML, Ning L, Gil CJ, Hwang B, Bauser-Heaton H, Chen H, and Serpooshan V
- Subjects
- Tissue Engineering methods, Hydrogels chemistry, Adhesives, Dopamine, Gelatin chemistry, Methacrylates chemistry, Printing, Three-Dimensional, Bioprinting methods, Tissue Adhesives
- Abstract
Adhesive tissue engineering scaffolds (ATESs) have emerged as an innovative alternative means, replacing sutures and bioglues, to secure the implants onto target tissues. Relying on their intrinsic tissue adhesion characteristics, ATES systems enable minimally invasive delivery of various scaffolds. This study investigates development of the first class of 3D bioprinted ATES constructs using functionalized hydrogel bioinks. Two ATES delivery strategies, in situ printing onto the adherend versus printing and then transferring to the target surface, are tested using two bioprinting methods, embedded versus air printing. Dopamine-modified methacrylated hyaluronic acid (HAMA-Dopa) and gelatin methacrylate (GelMA) are used as the main bioink components, enabling fabrication of scaffolds with enhanced adhesion and crosslinking properties. Results demonstrate that dopamine modification improved adhesive properties of the HAMA-Dopa/GelMA constructs under various loading conditions, while maintaining their structural fidelity, stability, mechanical properties, and biocompatibility. While directly printing onto the adherend yields superior adhesive strength, embedded printing followed by transfer to the target tissue demonstrates greater potential for translational applications. Together, these results demonstrate the potential of bioprinted ATESs as off-the-shelf medical devices for diverse biomedical applications., (© 2023 The Authors. Advanced Biology published by Wiley-VCH GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
11. Regionalization of Care in Congenital Interventional Cardiology.
- Author
-
Bauser-Heaton H, El-Said H, Hijazi ZM, Vincent RN, Zellers TM, and Ing FF
- Published
- 2023
- Full Text
- View/download PDF
12. Perspective on Pediatric/Congenital Cardiac Catheterization in Response to the First Wave of COVID.
- Author
-
Bauser-Heaton H
- Abstract
Competing Interests: Dr Bauser-Heaton is a proctor for W.S. Gore.
- Published
- 2022
- Full Text
- View/download PDF
13. Management of a large coronary artery fistula in a neonate.
- Author
-
McKiernan MA, Almasarweh S, Bauser-Heaton H, Chai PJ, and Rosenblum JM
- Published
- 2022
- Full Text
- View/download PDF
14. Tissue engineered drug delivery vehicles: Methods to monitor and regulate the release behavior.
- Author
-
Gil CJ, Li L, Hwang B, Cadena M, Theus AS, Finamore TA, Bauser-Heaton H, Mahmoudi M, Roeder RK, and Serpooshan V
- Subjects
- Excipients, Pharmaceutical Preparations, Tissue Scaffolds chemistry, Drug Delivery Systems, Tissue Engineering
- Abstract
Tissue engineering is a rapidly evolving, multidisciplinary field that aims at generating or regenerating 3D functional tissues for in vitro disease modeling and drug screening applications or for in vivo therapies. A variety of advanced biological and engineering methods are increasingly being used to further enhance and customize the functionality of tissue engineered scaffolds. To this end, tunable drug delivery and release mechanisms are incorporated into tissue engineering modalities to promote different therapeutic processes, thus, addressing challenges faced in the clinical applications. In this review, we elaborate the mechanisms and recent developments in different drug delivery vehicles, including the quantum dots, nano/micro particles, and molecular agents. Different loading strategies to incorporate the therapeutic reagents into the scaffolding structures are explored. Further, we discuss the main mechanisms to tune and monitor/quantify the release kinetics of embedded drugs from engineered scaffolds. We also survey the current trend of drug delivery using stimuli driven biopolymer scaffolds to enable precise spatiotemporal control of the release behavior. Recent advancements, challenges facing current scaffold-based drug delivery approaches, and areas of future research are discussed., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
15. 3D bioprinting of nanoparticle-laden hydrogel scaffolds with enhanced antibacterial and imaging properties.
- Author
-
Theus AS, Ning L, Kabboul G, Hwang B, Tomov ML, LaRock CN, Bauser-Heaton H, Mahmoudi M, and Serpooshan V
- Abstract
Biomaterial-associated microbial contaminations in biologically conducive three-dimensional (3D) tissue-engineered constructs have significantly limited the clinical applications of scaffold systems. To prevent such infections, antimicrobial biomaterials are rapidly evolving. Yet, the use of such materials in bioprinting-based approaches of scaffold fabrication has not been examined. This study introduces a new generation of bacteriostatic gelatin methacryloyl (GelMA)-based bioinks, incorporated with varying doses of antibacterial superparamagnetic iron oxide nanoparticles (SPIONs). The SPION-laden GelMA scaffolds showed significant resistance against the Staphylococcus aureus growth, while providing a contrast in magnetic resonance imaging. We simulated the bacterial contamination of cellular 3D GelMA scaffolds in vitro and demonstrated the significant effect of functionalized scaffolds in inhibiting bacterial growth, while maintaining cell viability and growth. Together, these results present a new promising class of functionalized bioinks to 3D bioprint tissue-engineered scaffold with markedly enhanced properties for the use in a variety of in vitro and clinical applications., Competing Interests: Author V.S. is a Guest Editor on the Advanced Manufacturing of Tissue Constructs Special Issue published in iScience. Author M.M. discloses that (i) he is a co-founder and director of the Academic Parity Movement (www.paritymovement.org), a non-profit organization dedicated to addressing academic discrimination, violence and incivility; (ii) he is a Founding Partner at Partners in Global Wound Care (PGWC); and (iii) he receives royalties/honoraria for his published books, plenary lectures, and licensed patents., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
16. Stenting of the Patent Ductus Arteriosus: A Meta-analysis and Literature Review.
- Author
-
Bauser-Heaton H, Price K, Weber R, and El-Said H
- Abstract
Background: Patent ductus arteriosus (PDA) stent placement and systemic-pulmonary surgical shunt procedure can both be performed as palliation for infants with duct-dependent pulmonary circulation. The aim of this meta-analysis and literature review was to compare outcomes and study populations between the 2 methods as well as review the technical considerations and complications of PDA stenting., Methods: A systematic search was conducted using the PubMed database and meta-analysis was performed. Risk ratio and mean difference were used to compare the reported outcomes of studies across patients receiving PDA stent and surgical shunt., Results: In total, 1094 patients from 8 comparative observational studies were included. The PDA stent group had a lower mortality rate and a shorter hospital length of stay than the systemic-pulmonary surgical shunt group, although at the expense of increased reintervention rates. There were higher proportions of patients with single-ventricle physiology and single-source pulmonary blood flow in the surgical shunt group., Conclusions: PDA stenting appears to be a noninferior or possibly superior method of palliation for duct-dependent pulmonary circulation compared with systemic-pulmonary surgical shunt, recognizing, however, that patients receiving surgical shunt more often had single-ventricle physiology or single-source pulmonary blood flow in this meta-analysis., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
17. Health Care Disparities in Congenital Cardiology: Considerations Through the Lens of an Interventional Cardiologist.
- Author
-
Bauser-Heaton H, Aggarwal V, Graziano JN, Ligon RA, Keeshan B, Stapleton G, Sutton NJ, Fleming G, El-Said H, Kim D, and Ing FF
- Abstract
When resources in a society are dispersed unevenly, generally through allocation standards, distinct patterns emerge along lines of socially defined categories of people. Power, religion, kinship, prestige, race, ethnicity, gender, age, sexual orientation, and class all play a role in determining who has access to social goods in society. In most cases, social inequality refers to a lack of equality of outcome, but it can also refer to a lack of equality of access to opportunity. Unfortunately, health care is not immune to these social disparities and/or inequalities. These health care disparities in interventional cardiology were recently brought to the forefront by the Society for Cardiovascular Angiography and Interventions (SCAI) as a major focus of 2020-2021. In a recent publication, unique factors leading to disparities were reported to exist among the subsections of interventional cardiology. The congenital heart disease council of SCAI created a task force to further investigate the unique challenges and disparities impacting the practice of congenital heart disease and pediatric cardiology., (© 2022 Published by Elsevier Inc. on behalf of the Society for Cardiovascular Angiography and Interventions Foundation.)
- Published
- 2022
- Full Text
- View/download PDF
18. A 3D Bioprinted In Vitro Model of Pulmonary Artery Atresia to Evaluate Endothelial Cell Response to Microenvironment.
- Author
-
Tomov ML, Perez L, Ning L, Chen H, Jing B, Mingee A, Ibrahim S, Theus AS, Kabboul G, Do K, Bhamidipati SR, Fischbach J, McCoy K, Zambrano BA, Zhang J, Avazmohammadi R, Mantalaris A, Lindsey BD, Frakes D, Dasi LP, Serpooshan V, and Bauser-Heaton H
- Published
- 2022
- Full Text
- View/download PDF
19. Transcatheter Recanalization of Atretic Pulmonary Veins in Infants and Children.
- Author
-
Patel JD, Mandhani M, Gray R, Pettus J, McCracken CE, Thomas A, Bauser-Heaton H, Kim DW, and Petit CJ
- Subjects
- Child, Humans, Infant, Retrospective Studies, Stents, Treatment Outcome, Angioplasty, Balloon adverse effects, Drug-Eluting Stents, Heart Defects, Congenital, Pulmonary Veins diagnostic imaging, Stenosis, Pulmonary Vein diagnostic imaging, Stenosis, Pulmonary Vein etiology, Stenosis, Pulmonary Vein therapy
- Abstract
Background: Pulmonary vein stenosis is a progressive disease associated with a high rate of mortality in children. If left untreated, myofibroblastic proliferation can lead to pulmonary vein atresia (PVA). In our experience, transcatheter recanalization has emerged as a favorable interventional option. We sought to determine the acute success rate of recanalization of atretic pulmonary veins and mid-term outcomes of individual veins after recanalization., Methods: We reviewed all patients with PVA at our institution between 2008 and 2020 diagnosed by either catheterization or cardiac computed tomography. All veins with successful recanalization were reviewed and procedural success rate and patency rate were noted. Competing risk analysis was performed to demonstrate outcomes of individual atretic veins longitudinally., Results: Between 2008 and 2020, our institution diagnosed and treated 131 patients with pulmonary vein stenosis. Of these, 61 patients developed atresia of at least one pulmonary vein. In total, there were 97 atretic pulmonary veins within this group. Successful recanalization was accomplished in 47/97 (48.5%) atretic veins. No atretic pulmonary veins were successfully recanalized before 2012. The majority of veins were recanalized between 2017 and 2020-39/56 (70%). The most common intervention after recanalization was drug-eluting stent placement. At 2-year follow-up 42.6% of recanalized veins (20.6% of all atretic veins) remained patent with a median of 4 reinterventions per person., Conclusions: Transcatheter recanalization of PVA can result in successful reestablishment of flow to affected pulmonary veins in many cases. Drug-eluting stent implantation was the most common intervention performed immediately post-recanalization. Vein patency was maintained in 42.6% of patients at 2-year follow-up from recanalization with appropriate surveillance and reintervention. Overall, only a small portion of atretic pulmonary veins underwent successful recanalization with maintained vessel patency at follow-up. Irrespective of successful recanalization, there was no detectable survival difference between the more recently treated PVA cohort and non-PVA cohort.
- Published
- 2022
- Full Text
- View/download PDF
20. Selective Valve Removal for Melody Valve Endocarditis: Practice Variations in a Multicenter Experience.
- Author
-
Davtyan A, Guyon PW, El-Sabrout HR, Ponder R, Ramchandar N, Weber R, Zayed W, Ratnayaka K, Nigro JJ, Moore JW, Bauser-Heaton H, Alshawabkeh L, Reeves RR, Levi D, Aboulhosn J, Justino H, Bradley J, and El-Said HG
- Subjects
- Cardiac Catheterization adverse effects, Humans, Prosthesis Design, Retrospective Studies, Treatment Outcome, Endocarditis etiology, Endocarditis surgery, Endocarditis, Bacterial drug therapy, Endocarditis, Bacterial surgery, Heart Valve Prosthesis adverse effects, Heart Valve Prosthesis Implantation adverse effects, Pulmonary Valve surgery, Pulmonary Valve Insufficiency surgery
- Abstract
Guidelines for management of Melody transcatheter pulmonary valve (TPV) infective endocarditis (IE) are lacking. We aimed to identify factors associated with surgical valve removal versus antimicrobial therapy in Melody TPV IE. Multicenter retrospective analysis of all patients receiving Melody TPV from 10/2010 to 3/2019 was performed to identify cases of IE. Surgical explants versus non-surgical cases were compared. Of the 663 Melody TPV implants, there were 66 cases of IE in 59 patients (59/663, 8.8%). 39/66 (59%) were treated with IV antimicrobials and 27/66(41%) underwent valve explantation. 26/59 patients (44%) were treated medically without explantation or recurrence with average follow-up time of 3.5 years (range:1-9). 32% of Streptococcus cases, 53% of MSSA, and all MRSA cases were explanted. 2 of the 4 deaths had MSSA. CART analysis demonstrated two important parameters associated with explantation: a peak echo gradient ≥ 47 mmHg at IE diagnosis(OR 10.6, p < 0.001) and a peak echo gradient increase of > 24 mmHg compared to baseline (OR 6.7, p = 0.01). Rates of explantation varied by institution (27 to 64%). In our multicenter experience, 44% of patients with Melody IE were successfully medically treated without valve explantation or recurrence. The degree of valve stenosis at time of IE diagnosis was strongly associated with explantation. Rates of explantation varied significantly among the institutions., (© 2021. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
21. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement.
- Author
-
McElhinney DB, Zhang Y, Levi DS, Georgiev S, Biernacka EK, Goldstein BH, Shahanavaz S, Qureshi AM, Cabalka AK, Bauser-Heaton H, Torres AJ, Morray BH, Armstrong AK, Millan-Iturbe O, Peng LF, Aboulhosn JA, Rużyłło W, Berger F, Sondergaard L, Schranz D, Cheatham JP, Jones TK, Ewert P, and Schubert S
- Subjects
- Adolescent, Adult, Age Factors, Child, Child, Preschool, Defibrillators, Implantable, Endocarditis epidemiology, Female, Heart Valve Prosthesis, Humans, Infant, Infant, Newborn, Male, Middle Aged, Pacemaker, Artificial, Registries, Young Adult, Heart Valve Prosthesis Implantation mortality, Pulmonary Valve surgery, Reoperation statistics & numerical data
- Abstract
Background: Transcatheter pulmonary valve (TPV) replacement (TPVR) has become the standard therapy for postoperative pulmonary outflow tract dysfunction in patients with a prosthetic conduit/valve, but there is limited information about risk factors for death or reintervention after this procedure., Objectives: This study sought to evaluate mid- and long-term outcomes after TPVR in a large multicenter cohort., Methods: International registry focused on time-related outcomes after TPVR., Results: Investigators submitted data for 2,476 patients who underwent TPVR and were followed up for 8,475 patient-years. A total of 95 patients died after TPVR, most commonly from heart failure (n = 24). The cumulative incidence of death was 8.9% (95% CI: 6.9%-11.5%) 8 years after TPVR. On multivariable analysis, age at TPVR (HR: 1.04 per year; 95% CI: 1.03-1.06 per year; P < 0.001), a prosthetic valve in other positions (HR: 2.1; 95% CI: 1.2-3.7; P = 0.014), and an existing transvenous pacemaker/implantable cardioverter-defibrillator (HR: 2.1; 95% CI: 1.3-3.4; P = 0.004) were associated with death. A total of 258 patients underwent TPV reintervention. At 8 years, the cumulative incidence of any TPV reintervention was 25.1% (95% CI: 21.8%-28.5%) and of surgical TPV reintervention was 14.4% (95% CI: 11.9%-17.2%). Risk factors for surgical reintervention included age (0.95 per year [95% CI: 0.93-0.97 per year]; P < 0.001), prior endocarditis (2.5 [95% CI: 1.4-4.3]; P = 0.001), TPVR into a stented bioprosthetic valve (1.7 [95% CI: 1.2-2.5]; P = 0.007), and postimplant gradient (1.4 per 10 mm Hg [95% CI: 1.2-1.7 per 10 mm Hg]: P < 0.001)., Conclusions: These findings support the conclusion that survival and freedom from reintervention or surgery after TPVR are generally comparable to outcomes of surgical conduit/valve replacement across a wide age range., Competing Interests: Funding Support and Author Disclosures Dr McElhinney has served as a consultant for Medtronic. Dr Levi has served as a consultant for Edwards and Medtronic. Dr Goldstein has served as a consultant for Medtronic. Dr Shahanavaz has served as a consultant for Edwards and Medtronic. Dr Qureshi has served as a consultant for Edwards, Medtronic, W.L. Gore and Associates, and Abiomed Inc. Dr Cabalka has served as a consultant for Medtronic. Dr Torres has served as a proctor for Edwards. Dr Morray has served as a consultant for Medtronic. Dr Armstrong has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards. Dr Aboulhosn has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards. Dr Berger has served as a consultant for Medtronic. Dr Sondergaard has served as a consultant for and received research grants from Edwards and Medtronic. Dr Schranz has served as a consultant for Medtronic. Dr Jones has served as a consultant for and received research grants from Edwards and Medtronic. Dr Cheatham has served as a consultant for Medtronic and NuMED. Dr Schubert has served as a proctor for Abbott, Edwards, Gore, Lifetech, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
22. Comparison of Patent Ductus Arteriosus Stent and Blalock-Taussig Shunt as Palliation for Neonates with Sole Source Ductal-Dependent Pulmonary Blood Flow: Results from the Congenital Catheterization Research Collaborative.
- Author
-
Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC, Ligon RA, Gartenberg A, Aggarwal V, Shashidharan S, McCracken CE, Kelleman MS, and Petit CJ
- Subjects
- Cardiac Catheterization, Humans, Infant, Newborn, Pulmonary Artery surgery, Pulmonary Circulation, Retrospective Studies, Stents, Treatment Outcome, Blalock-Taussig Procedure, Ductus Arteriosus surgery, Ductus Arteriosus, Patent surgery
- Abstract
Patent ductus arteriosus (PDA) stenting is an accepted method for securing pulmonary blood flow in cyanotic neonates. In neonates with pulmonary atresia and single source ductal-dependent pulmonary blood flow (SSPBF), PDA stenting remains controversial. We sought to evaluate outcomes in neonates with SSPBF, comparing PDA stenting and surgical Blalock-Taussig shunt (BTS). Neonates with SSPBF who underwent PDA stenting or BTS at the four centers of the Congenital Catheterization Research Collaborative from January 2008 to December 2015 were retrospectively reviewed. Reintervention on the BTS or PDA stent prior to planned surgical repair served as the primary endpoint. Additional analyses of peri-procedural complications, interventions, and pulmonary artery growth were performed. A propensity score was utilized to adjust for differences in factors. Thirty-five patients with PDA stents and 156 patients with BTS were included. The cohorts had similar baseline characteristics, procedural complications, and mortality. Interstage reintervention rates were higher in the PDA stent cohort (48.6% vs. 15.4%, p < 0.001)., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
23. A 3D Bioprinted In Vitro Model of Pulmonary Artery Atresia to Evaluate Endothelial Cell Response to Microenvironment.
- Author
-
Tomov ML, Perez L, Ning L, Chen H, Jing B, Mingee A, Ibrahim S, Theus AS, Kabboul G, Do K, Bhamidipati SR, Fischbach J, McCoy K, Zambrano BA, Zhang J, Avazmohammadi R, Mantalaris A, Lindsey BD, Frakes D, Dasi LP, Serpooshan V, and Bauser-Heaton H
- Subjects
- Anastomosis, Surgical, Hemodynamics, Humans, Models, Cardiovascular, Printing, Three-Dimensional, Stress, Mechanical, Bioprinting, Endothelial Cells, Pulmonary Artery surgery
- Abstract
Vascular atresia are often treated via transcatheter recanalization or surgical vascular anastomosis due to congenital malformations or coronary occlusions. The cellular response to vascular anastomosis or recanalization is, however, largely unknown and current techniques rely on restoration rather than optimization of flow into the atretic arteries. An improved understanding of cellular response post anastomosis may result in reduced restenosis. Here, an in vitro platform is used to model anastomosis in pulmonary arteries (PAs) and for procedural planning to reduce vascular restenosis. Bifurcated PAs are bioprinted within 3D hydrogel constructs to simulate a reestablished intervascular connection. The PA models are seeded with human endothelial cells and perfused at physiological flow rate to form endothelium. Particle image velocimetry and computational fluid dynamics modeling show close agreement in quantifying flow velocity and wall shear stress within the bioprinted arteries. These data are used to identify regions with greatest levels of shear stress alterations, prone to stenosis. Vascular geometry and flow hemodynamics significantly affect endothelial cell viability, proliferation, alignment, microcapillary formation, and metabolic bioprofiles. These integrated in vitro-in silico methods establish a unique platform to study complex cardiovascular diseases and can lead to direct clinical improvements in surgical planning for diseases of disturbed flow., (© 2021 Wiley-VCH GmbH.)
- Published
- 2021
- Full Text
- View/download PDF
24. N-terminal pro-B-type-natriuretic peptide as a screening tool for pulmonary hypertension in the paediatric population.
- Author
-
Dasgupta S, Bettermann E, Kelleman M, Kanaan U, Sachdeva R, Petit C, Kim D, Vincent R, and Bauser-Heaton H
- Subjects
- Biomarkers, Child, Humans, Prospective Studies, Hypertension, Pulmonary diagnosis, Natriuretic Peptide, Brain blood, Peptide Fragments blood
- Abstract
Background: Although cardiac catheterisation (cath) is the diagnostic test for pulmonary hypertension, it is an invasive procedure. Echocardiography (echo) is commonly used for the non-invasive diagnosis of pulmonary hypertension but maybe limited by lack of adequate signals. Therefore, emphasis has been placed on biomarkers as a potential diagnostic tool. No prior paediatric studies have simultaneously compared N-terminal pro-B-type-natriuretic peptide (NTproBNP) with cath/echo as a potential diagnostic tool. The aim of this study was to determine if NTproBNP was a reliable diagnostic tool for pulmonary hypertension in this population., Methods: Patients were divided into Study (echo evidence/established diagnosis of pulmonary hypertension undergoing cath) and Control (cath for small atrial septal defect/patent ductus arteriosus and endomyocardial biopsy post cardiac transplant) groups. NTproBNP, cath/echo data were obtained., Results: Thirty-one patients met inclusion criteria (10 Study, 21 Control). Median NTproBNP was significantly higher in the Study group. Echo parameters including transannular plane systolic excursion z scores, pulmonary artery acceleration time and right ventricular fractional area change were lower in the Study group and correlated negatively with NTproBNP. Receiver operation characteristic curve analysis demonstrated NTproBNP > 389 pg/ml was 87% specific for the diagnosis of pulmonary hypertension with the addition of pulmonary artery acceleration time improving the specificity., Conclusions: NTproBNP may be a valuable adjunctive diagnostic tool for pulmonary hypertension in the paediatric population. Echo measures of transannular plane systolic excursion z score, pulmonary artery acceleration time and right ventricular fractional area change had negative correlations with NTproBNP. The utility of NTproBNP as a screening tool for pulmonary hypertension requires validation in a population with unknown pulmonary hypertension status.
- Published
- 2021
- Full Text
- View/download PDF
25. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement.
- Author
-
McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM, Torres AJ, Shahanavaz S, Goldstein BH, Cabalka AK, Bauser-Heaton H, Georgiev S, Berger F, Millan-Iturbe O, Peng LF, Armstrong AK, Levi DS, Fronczak-Jakubczyk A, Sondergaard L, Anderson JH, Schranz D, Jones TK, Cheatham JP, Schubert S, and Ewert P
- Subjects
- Adult, Cardiac Catheterization methods, Female, Humans, Incidence, International Cooperation, Male, Registries statistics & numerical data, Staphylococcus aureus isolation & purification, Ventricular Outflow Obstruction etiology, Ventricular Outflow Obstruction surgery, Viridans Streptococci isolation & purification, Endocarditis etiology, Endocarditis microbiology, Endocarditis mortality, Endocarditis surgery, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation methods, Heart Valve Prosthesis Implantation statistics & numerical data, Pulmonary Valve surgery, Reoperation methods, Reoperation statistics & numerical data
- Abstract
Background: Endocarditis has emerged as one of the most impactful adverse events after transcatheter pulmonary valve replacement (TPVR), but there is limited information about risk factors for and outcomes of this complication., Objectives: The purpose of this study was to evaluate risk factors for and outcomes of endocarditis in a large multicenter cohort., Methods: The authors established an international registry focused on characterizing endocarditis after TPVR, including the incidence, risk factors, characteristics, and outcomes., Results: Investigators submitted data for 2,476 patients who underwent TPVR between July 2005 and March 2020 and were followed for 8,475 patient-years. In total, 182 patients were diagnosed with endocarditis a median of 2.7 years after TPVR, for a cumulative incidence of 9.5% (95% CI: 7.9%-11.1%) at 5 years and 16.9% (95% CI: 14.2%-19.8%) at 8 years (accounting for competing risks: death, heart transplant, and explant) and an annualized incidence of 2.2 per 100 patient-years. Staphylococcus aureus and Viridans group Streptococcus species together accounted for 56% of cases. Multivariable analysis confirmed that younger age, a previous history of endocarditis, and a higher residual gradient were risk factors for endocarditis, but transcatheter pulmonary valve type was not. Overall, right ventricular outflow tract (RVOT) reintervention was less often to treat endocarditis than for other reasons, but valve explant was more often caused by endocarditis. Endocarditis was severe in 44% of patients, and 12 patients (6.6%) died, nearly all of whom were infected with Staphylococcus aureus., Conclusions: The incidence of endocarditis in this multicenter registry was constant over time and consistent with prior smaller studies. The findings of this study, along with ongoing efforts to understand and mitigate risk, will be critical to improve the lifetime management of patients with heart disease involving the RVOT. Although endocarditis can be a serious adverse outcome, TPVR remains an important tool in the management of RVOT dysfunction., Competing Interests: Funding Support and Author Disclosures Drs McElhinney, Morray, Goldstein, Cabalka, Berger, and Schranz have served as consultants for Medtronic. Drs Aboulhosn and Levi have served as consultants for Edwards and Medtronic; and has received research grants from Edwards. Dr Qureshi has served as a consultant for Edwards, Medtronic, W.L. Gore and Associates, and Abiomed Inc. Dr Torres has served as a proctor for Edwards. Dr Shahanavaz has served as a consultant for Edwards and Medtronic. Dr Armstrong has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards. Dr Sondergaard has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards and Medtronic. Dr Jones has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards and Medtronic. Dr Cheatham has served as a consultant for Medtronic and NuMED. Dr Schubert has served as a proctor for Abbott, Edwards, Gore, Lifetech, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
26. Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.
- Author
-
Grines CL, Klein AJ, Bauser-Heaton H, Alkhouli M, Katukuri N, Aggarwal V, Altin SE, Batchelor WB, Blankenship JC, Fakorede F, Hawkins B, Hernandez GA, Ijioma N, Keeshan B, Li J, Ligon RA, Pineda A, Sandoval Y, and Young MN
- Subjects
- Aged, 80 and over, Ethnicity, Female, Health Status Disparities, Healthcare Disparities, Hispanic or Latino, Humans, Treatment Outcome, United States epidemiology, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital therapy, Transcatheter Aortic Valve Replacement
- Abstract
Cardiovascular disease (CVD) remains the leading cause of death in the United States. However, percutaneous interventional cardiovascular therapies are often underutilized in Blacks, Hispanics, and women and may contribute to excess morbidity and mortality in these vulnerable populations. The Society for Cardiovascular Angiography and Interventions (SCAI) is committed to reducing racial, ethnic, and sex-based treatment disparities in interventional cardiology patients. Accordingly, each of the SCAI Clinical Interest Councils (coronary, peripheral, structural, and congenital heart disease [CHD]) participated in the development of this whitepaper addressing disparities in diagnosis, treatment, and outcomes in underserved populations. The councils were charged with summarizing the available data on prevalence, treatment, and outcomes and elucidating potential reasons for any disparities. Given the huge changes in racial and ethnic composition by age in the United States (Figure 1), it was difficult to determine disparities in rates of diagnosis and we expected to find some racial differences in prevalence of disease. For example, since the average age of patients undergoing transcatheter aortic valve replacement (TAVR) is 80 years, one may expect 80% of TAVR patients to be non-Hispanic White. Conversely, only 50% of congenital heart interventions would be expected to be performed in non-Hispanic Whites. Finally, we identified opportunities for SCAI to advance clinical care and equity for our patients, regardless of sex, ethnicity, or race., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
27. Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization.
- Author
-
Vaiyani D, Kelleman M, Downey LA, Kanaan U, Petit CJ, and Bauser-Heaton H
- Subjects
- Anesthesia adverse effects, Cardiac Catheterization methods, Child, Child, Preschool, Female, Heart Arrest epidemiology, Heart Arrest etiology, Heart Defects, Congenital diagnosis, Heart Defects, Congenital therapy, Hemodynamics, Humans, Hypertension, Pulmonary mortality, Infant, Male, Nitric Oxide, Pulmonary Artery physiopathology, Pulmonary Wedge Pressure, Retrospective Studies, Risk Factors, Time Factors, Vascular Resistance, Cardiac Catheterization adverse effects, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary therapy
- Abstract
Pulmonary hypertension (PH) can lead to progressive heart failure with high morbidity and mortality. Cardiac catheterization (CC) is the gold standard for diagnosis and response to vasodilatory medications. The invasive nature of CC and associated anesthesia predispose this patient population to adverse events including death. Catheterization records were queried from 1/1/2011 to 10/31/2016. Patients with PH, defined as pulmonary vascular resistance (PVR) greater than 3 WU m
2 , pulmonary artery pressure above 20 mmHg, and pulmonary wedge pressure less than or equal to 15 mmHg, who underwent hemodynamic CC were included in this retrospective study. Both patients with and without congenital heart disease were included. There were 198 CC in 191 patients. Adverse events (n = 28, 14.1%) included cardiac arrest, increased respiratory support requiring ICU care, PH crisis, bradycardia/hypotension requiring intervention, and arrhythmias. Odds of an adverse event increased by 22% for every 15-min increase in procedure times (OR 1.22, CI 1.01-1.39, p = 0.002) and were significantly increased for procedures longer than 80 min (OR 3.75, CI 1.56-9.00, p = 0.007) (Fig. 1). Patients with an adverse event had higher mean pulmonary artery pressures while breathing oxygen (43 [35-58] versus 34 [27-44] mmHg, p = 0.017) and oxygen with inhaled nitric oxide (37 [32-56] versus 32 [25-40] mmHg, p = 0.026). Females carried more risk than males (OR 3.88, CI 1.44-10.40, p = 0.007). Younger age, medication regimens, prematurity, and genetic disease did not carry an increased risk. Adverse events are common in pediatric patients with PH undergoing CC. The risk of adverse events correlates with greater procedure times and higher mean pulmonary artery pressure. Minimizing procedure time may improve patient outcomes.- Published
- 2021
- Full Text
- View/download PDF
28. Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of Fallot.
- Author
-
Goldstein BH, Petit CJ, Qureshi AM, McCracken CE, Kelleman MS, Nicholson GT, Law MA, Meadows JJ, Zampi JD, Shahanavaz S, Mascio CE, Chai PJ, Romano JC, Batlivala SP, Maskatia SA, Asztalos IB, Kamsheh AM, Healan SJ, Smith JD, Ligon RA, Pettus JA, Juma S, Raulston JEB, Hock KM, Pajk AL, Eilers LF, Khan HQ, Merritt TC, Canter M, Juergensen S, Rinderknecht FA, Bauser-Heaton H, and Glatz AC
- Subjects
- Cohort Studies, Cyanosis etiology, Cyanosis surgery, Heart Transplantation statistics & numerical data, Humans, Infant, Newborn, Intensive Care Units, Neonatal, Length of Stay statistics & numerical data, Reoperation statistics & numerical data, Respiration, Artificial statistics & numerical data, Retrospective Studies, Tetralogy of Fallot mortality, Time Factors, Tetralogy of Fallot surgery
- Abstract
Background: Neonates with tetralogy of Fallot and symptomatic cyanosis (sTOF) require early intervention., Objectives: This study sought to perform a balanced multicenter comparison of staged repair (SR) (initial palliation [IP] and subsequent complete repair [CR]) versus primary repair (PR) treatment strategies., Methods: Consecutive neonates with sTOF who underwent IP or PR at ≤30 days of age from 2005 to 2017 were retrospectively reviewed from the Congenital Cardiac Research Collaborative. The primary outcome was death. Secondary outcomes included component (IP, CR, PR) and cumulative (SR): hospital and intensive care unit lengths of stay; durations of cardiopulmonary bypass, anesthesia, ventilation, and inotrope use; and complication and reintervention rates. Outcomes were compared using propensity score adjustment., Results: The cohort consisted of 342 patients who underwent SR (IP: surgical, n = 256; transcatheter, n = 86) and 230 patients who underwent PR. Pre-procedural ventilation, prematurity, DiGeorge syndrome, and pulmonary atresia were more common in the SR group (p ≤0.01). The observed risk of death was not different between the groups (10.2% vs 7.4%; p = 0.25) at median 4.3 years. After adjustment, the hazard of death remained similar between groups (hazard ratio: 0.82; 95% confidence interval: 0.49 to 1.38; p = 0.456), but it favored SR during early follow-up (<4 months; p = 0.041). Secondary outcomes favored the SR group in component analysis, whereas they largely favored PR in cumulative analysis. Reintervention risk was higher in the SR group (p = 0.002)., Conclusions: In this multicenter comparison of SR or PR for management of neonates with sTOF, adjusted for patient-related factors, early mortality and neonatal morbidity were lower in the SR group, but cumulative morbidity and reinterventions favored the PR group, findings suggesting potential benefits to each strategy., Competing Interests: Funding Support and Author Disclosures Financial support for this research was derived, in part, from the Kennedy Hammill Pediatric Cardiac Research Fund, the Liam Sexton Foundation, and A Heart Like Ava. Dr. Goldstein has reported consulting relationships with Medtronic, W.L. Gore & Associates, and Edwards Lifesciences; and is an advisory board member for PECA Labs. Dr. Qureshi has reported consulting relationships with W.L Gore & Associates, Edwards Lifesciences, and Abiomed. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
29. Impact of Treatment Strategy on Outcomes in Isolated Pulmonary Artery of Ductal Origin.
- Author
-
Goldstein BH, Qureshi AM, Meadows JJ, Nicholson GT, Bauser-Heaton H, Petit CJ, Pater C, Kelleman MS, Morales DLS, Mery CM, Shashidharan S, Mascio CE, Mozumdar N, Aggarwal V, Agrawal H, Ligon RA, Christensen J, McCracken CE, and Glatz AC
- Subjects
- Cardiac Catheterization methods, Ductus Arteriosus, Patent surgery, Female, Humans, Infant, Infant, Newborn, Male, Palliative Care methods, Reoperation methods, Retrospective Studies, Stents, Treatment Outcome, Cardiac Surgical Procedures methods, Heart Defects, Congenital surgery, Pulmonary Artery abnormalities, Pulmonary Artery surgery
- Abstract
Isolated pulmonary artery (PA) of ductal origin (IPADO) is a rare cardiac defect which requires surgical repair, with or without preceding palliation. We sought to determine the impact of treatment strategy on outcomes. Retrospective study of consecutive patients with IPADO that underwent staged or primary repair from 1/05 to 9/16 at 6 Congenital Cardiac Research Collaborative centers. Patients with single ventricle physiology, major aortopulmonary collaterals, or bilateral IPADO were excluded. Primary outcome was isolated PA z-score at late follow-up. Secondary outcomes included PA symmetry index (isolated:confluent PA diameter) and reintervention burden. Propensity score adjustment was used to account for baseline differences. Of 60 patients in the study cohort, 26 (43%) underwent staged and 34 (57%) primary repair. The staged and primary repair groups differed in weight at diagnosis and presence of other heart disease but not in baseline PA dimensions. Staged patients underwent ductal stent (n = 16) or surgical shunt (n = 10) placement followed by repair at 210 vs. 21 days in the primary repair group (p < 0.001). At median follow-up of 4.5 years post-repair, after adjustment, isolated PA z-score (- 0.74 [- 1.75, - 0.26] vs. - 1.95 [- 2.91, - 1.59], p = 0.012) and PA symmetry index (0.81 [0.49, 1.0] vs. 0.55 [0.48, 0.69], p = 0.042) significantly favored the staged repair group. Freedom from PA reintervention was not different between groups (adjusted HR 0.78 [0.41, 1.48]; p = 0.445). A staged approach to repair of IPADO is associated with superior isolated PA size and symmetry at late follow-up. Consideration should be given to initial palliation in IPADO patients, when feasible.
- Published
- 2021
- Full Text
- View/download PDF
30. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis.
- Author
-
Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D, Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer DT, and McElhinney DB
- Subjects
- Adolescent, Adult, Bioprosthesis, Child, Endovascular Procedures instrumentation, Endovascular Procedures methods, Female, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation methods, Humans, Male, Middle Aged, Retrospective Studies, Young Adult, Endovascular Procedures statistics & numerical data, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation statistics & numerical data, Pulmonary Valve, Registries
- Abstract
Background: There are limited published data focused on outcomes of transcatheter pulmonary valve replacement (TPVR) with either a Sapien XT or Sapien 3 (S3) valve., Objectives: This study sought to report short-term outcomes in a large cohort of patients who underwent TPVR with either a Sapien XT or S3 valve., Methods: Data were entered retrospectively into a multicenter registry for patients who underwent attempted TPVR with a Sapien XT or S3 valve. Patient-related, procedural, and short-term outcomes data were characterized overall and according to type of right ventricular outflow tract (RVOT) anatomy., Results: Twenty-three centers enrolled a total of 774 patients: 397 (51%) with a native/patched RVOT; 183 (24%) with a conduit; and 194 (25%) with a bioprosthetic valve. The S3 was used in 78% of patients, and the XT was used in 22%, with most patients receiving a 29-mm (39%) or 26-mm (34%) valve. The implant was technically successful in 754 (97.4%) patients. Serious adverse events were reported in 67 patients (10%), with no difference between RVOT anatomy groups. Fourteen patients underwent urgent surgery. Nine patients had a second valve implanted. Among patients with available data, tricuspid valve injury was documented in 11 (1.7%), and 9 others (1.3%) had new moderate or severe regurgitation 2 grades higher than pre-implantation, for 20 (3.0%) total patients with tricuspid valve complications. Valve function at discharge was excellent in most patients, but 58 (8.5%) had moderate or greater pulmonary regurgitation or maximum Doppler gradients >40 mm Hg. During limited follow-up (n = 349; median: 12 months), 9 patients were diagnosed with endocarditis, and 17 additional patients underwent surgical valve replacement or valve-in-valve TPVR., Conclusions: Acute outcomes after TPVR with balloon-expandable valves were generally excellent in all types of RVOT. Additional data and longer follow-up will be necessary to gain insight into these issues., Competing Interests: Author Disclosures This study received funding from Edwards Lifesciences, Inc., to support data management and analysis, but there was no direct participation by employees of Edwards Lifesciences, Inc. Drs. Aboulhosn, Asnes, and Torres have served as proctors for Edwards Lifesciences. Dr. Balzer has served as a proctor for Edwards Lifesciences and Medtronic. Drs. Berman and Zahn have served as a proctor and consultant for Edwards Lifesciences, Abbott, and Medtronic. Dr. Gillespie has served as a consultant for Medtronic. Dr. Goldstein has served as a consultant for Medtronic; has served as a consultant and proctor for W.L. Gore & Associates; and has served on the PECA Labs Advisory Board. Dr. Levi has served as a consultant and proctor for Edwards Lifesciences. Dr. McElhinney has served as a consultant and proctor for Medtronic. Dr. Morgan has served as a consultant and proctor for Edwards Lifesciences; and has served as a consultant for Medtronic. Dr. Murray has served as a consultant for Medtronic and Abbott. Dr. Shahanavaz has served as a proctor for Edwards Lifesciences and Medtronic. Dr. Sathanandam has served as a proctor and consultant for Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
31. Biomechanical factors in three-dimensional tissue bioprinting.
- Author
-
Ning L, Gil CJ, Hwang B, Theus AS, Perez L, Tomov ML, Bauser-Heaton H, and Serpooshan V
- Abstract
3D bioprinting techniques have shown great promise in various fields of tissue engineering and regenerative medicine. Yet, creating a tissue construct that faithfully represents the tightly regulated composition, microenvironment, and function of native tissues is still challenging. Among various factors, biomechanics of bioprinting processes play fundamental roles in determining the ultimate outcome of manufactured constructs. This review provides a comprehensive and detailed overview on various biomechanical factors involved in tissue bioprinting, including those involved in pre, during, and post printing procedures. In preprinting processes, factors including viscosity, osmotic pressure, and injectability are reviewed and their influence on cell behavior during the bioink preparation is discussed, providing a basic guidance for the selection and optimization of bioinks. In during bioprinting processes, we review the key characteristics that determine the success of tissue manufacturing, including the rheological properties and surface tension of the bioink, printing flow rate control, process-induced mechanical forces, and the in situ cross-linking mechanisms. Advanced bioprinting techniques, including embedded and multi-material printing, are explored. For post printing steps, general techniques and equipment that are used for characterizing the biomechanical properties of printed tissue constructs are reviewed. Furthermore, the biomechanical interactions between printed constructs and various tissue/cell types are elaborated for both in vitro and in vivo applications. The review is concluded with an outlook regarding the significance of biomechanical processes in tissue bioprinting, presenting future directions to address some of the key challenges faced by the bioprinting community.
- Published
- 2020
- Full Text
- View/download PDF
32. Embedded 3D Bioprinting of Gelatin Methacryloyl-Based Constructs with Highly Tunable Structural Fidelity.
- Author
-
Ning L, Mehta R, Cao C, Theus A, Tomov M, Zhu N, Weeks ER, Bauser-Heaton H, and Serpooshan V
- Subjects
- Cells, Cultured, Gelatin chemistry, Human Umbilical Vein Endothelial Cells chemistry, Humans, Particle Size, Surface Properties, Acrylic Resins analysis, Methacrylates chemistry, Printing, Three-Dimensional
- Abstract
Three-dimensional (3D) bioprinting of hydrogel-based constructs at adequate consistency and reproducibility can be obtained through a compromise between the hydrogel's inherent instability and printing fidelity. There is an increasing demand to develop bioprinting modalities that enable high-fidelity fabrication of 3D hydrogel structures that closely correspond to the envisioned design. In this work, we performed a systematic, in-depth characterization and optimization of embedded 3D bioprinting to create 3D gelatin-methacryloyl (gelMA) structures with highly controlled fidelity using Carbopol as suspension bath. The role of various embedded printing process parameters in bioprinting fidelity was investigated using a combination of experimental and theoretical approaches. We examined the effect of rheological properties of gelMA and Carbopol at varying concentrations, as well as printing conditions on the volumetric flow rate of gelMA bioink. Printing speed was examined and optimized to successfully print gelMA into the support bath at varying Carbopol concentrations. Printing fidelity was characterized in terms of printed strand diameter, uniformity, angle, and area. The optimal Carbopol solution that retained filament shape at highest fidelity was determined. The efficacy of developed bioprinting approach was then demonstrated by fabricating 3D hydrogel constructs with varying geometries and visualized using an advanced synchrotron-based imaging technique. We also investigated the influence of the Carbopol medium on cross-linking and the resulting stiffness of gelMA constructs. Finally, in vitro cytotoxicity of the developed bioprinting approach was assessed by printing human umbilical vein endothelial cells encapsulated in the gelMA bioink. These results demonstrate the significance of the close interplay between bioink-support bath rheology and printing parameters and help to establish an optimized workflow for creating 3D hydrogel structures with high fidelity and cytocompatibility via embedded bioprinting techniques. This robust platform could further expand the application of bioprinted soft tissue constructs in a wide variety of biomedical applications.
- Published
- 2020
- Full Text
- View/download PDF
33. Percutaneous paraspinal access to the azygos vein to create a neo-vena cava.
- Author
-
Sorensen MW, Bauser-Heaton H, and Petit CJ
- Subjects
- Child, Preschool, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital physiopathology, Humans, Intracranial Hemorrhages diagnostic imaging, Intracranial Hemorrhages etiology, Intracranial Hemorrhages physiopathology, Male, Recovery of Function, Superior Vena Cava Syndrome diagnostic imaging, Superior Vena Cava Syndrome etiology, Superior Vena Cava Syndrome physiopathology, Treatment Outcome, Vena Cava, Superior diagnostic imaging, Vena Cava, Superior physiopathology, Venous Insufficiency diagnostic imaging, Venous Insufficiency etiology, Venous Insufficiency physiopathology, Azygos Vein surgery, Cardiac Surgical Procedures adverse effects, Decompression, Surgical, Heart Defects, Congenital surgery, Intracranial Hemorrhages surgery, Superior Vena Cava Syndrome surgery, Surgically-Created Structures, Vascular Surgical Procedures, Vena Cava, Superior surgery, Venous Insufficiency surgery
- Abstract
We present the case of a child with congenital heart disease repaired in infancy with diffuse central venous occlusions resulting in central venous insufficiency, superior vena cava (SVC) syndrome, and intracranial bleeds. He presented to the catheterization laboratory for multiple transcatheter interventions to recanalize central venous channels which were unsuccessful by conventional methods. Therefore, extravascular venous channels were created to decompress his upper body by creation of a neo-SVC and his lower body with a neo-azygos vein to the neo-SVC. The latter procedure required direct percutaneous access from a paraspinal approach in order to obtain continuity with the azygos vein. At latest follow-up the patient is clinically well and asymptomatic., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
34. Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: A multicenter study from the congenital catheterization research collaborative.
- Author
-
Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC, Nicholson GT, Meadows JJ, Depaolo JS, Aggarwal V, McCracken CE, Mossad EB, Wilson EC, and Petit CJ
- Subjects
- Cardiac Catheterization adverse effects, Ductus Arteriosus, Patent diagnostic imaging, Ductus Arteriosus, Patent physiopathology, Female, Humans, Infant, Newborn, Male, Punctures, Retrospective Studies, Treatment Outcome, Ultrasonography, Interventional, United States, Axillary Artery diagnostic imaging, Cardiac Catheterization instrumentation, Carotid Arteries diagnostic imaging, Catheterization, Peripheral adverse effects, Ductus Arteriosus, Patent therapy, Femoral Artery diagnostic imaging, Palliative Care, Pulmonary Circulation, Stents
- Abstract
Background: Carotid artery (CA) and axillary artery (AA) access are increasingly used for transcatheter stenting of the patent ductus arteriosus (PDA), although reports are limited., Methods: The Congenital Catheterization Research Collaborative (CCRC) reviewed multicenter data from infants who underwent PDA stenting via the CA or AA approach from 2008 to 2017, and compared outcomes to those of infants undergoing PDA stenting via the femoral artery (FA) approach. Post-procedure ultrasound (US) imaging was reviewed., Results: Forty-nine infants underwent PDA stenting from the CA (n = 43) or AA (n = 6) approach, compared with 55 infants who underwent PDA stenting from the FA approach. The PDA was the sole pulmonary blood flow (PBF) source in 61% of infants in the CA/AA cohort, compared with 33% of the FA cohort (p < .01). Ductal tortuosity for CA/AA cohort was Type I (straight) in 10 (20%), Type II (one turn) in 17 (35%), and Type III (multiple turns) in 22 (45%) infants and reflected a greater degree of tortuosity when compared to the FA cohort (p < .01). In 17 infants with CA/AA approach, the "flip technique" was used, and was associated with shorter procedure times for highly tortuous PDA (Type III) patients. Rates of procedural complications were similar across access sites. Most common complications were access site injury (thrombus or bleeding) and stent malposition. No complications were specifically related to the "flip technique.", Conclusions: Use of CA and AA approach for PDA stenting was found to be more commonly employed in sole source PBF and highly tortuous PDAs. Procedural modifications such as the "flip technique" may lead to shorter procedure times. CA and AA approaches are associated with a similar burden of procedural or late complications. Post-procedural surveillance of the CA and AA is suggested, given the incidence of vascular findings on US., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
35. Management outcomes of primary pulmonary vein stenosis.
- Author
-
Rosenblum JM, Altin HF, Gillespie SE, Bauser-Heaton H, Kanter KA, Sinha R, Cory M, and Alsoufi B
- Subjects
- Female, Georgia, Humans, Infant, Male, Postoperative Complications mortality, Postoperative Complications surgery, Recurrence, Reoperation, Retrospective Studies, Risk Factors, Severity of Illness Index, Stenosis, Pulmonary Vein diagnostic imaging, Stenosis, Pulmonary Vein mortality, Stenosis, Pulmonary Vein physiopathology, Time Factors, Treatment Failure, Stenosis, Pulmonary Vein surgery
- Abstract
Objectives: Primary pulmonary vein stenosis (PPVS) is increasingly diagnosed in children with no prior pulmonary vein intervention history, and management is challenging. We describe characteristics of patients who underwent surgical repair of PPVS at our center, and examine factors associated with treatment failures., Methods: A retrospective review of all patients who underwent surgical intervention for PPVS (2002-2016) was completed. Patients who had undergone prior cardiac surgery involving the pulmonary veins or atrial switch were excluded. Regression analyses were performed to examine characteristics, PPVS features, including severity score, and surgical details associated with treatment failures., Results: Thirty-four children underwent initial surgical intervention for PPVS. Median age was 8.9 months (interquartile range, 5.9-18.4 months). Most patients (n = 31; 91%) had unilateral pulmonary vein involvement and the median PPVS severity score was 3.5 (interquartile range, 3-5). On competing risk analysis, 1 year following surgical repair, 9% of patients had died, 14% had undergone reintervention, and 77% were alive without reintervention; at 5 years the numbers were 9%, 30%, and 61%, respectively. Factors associated with mortality included bilateral disease and PPVS severity score >6. Bilateral disease and PPVS severity score >5 were associated with reintervention risk., Conclusions: Multidisciplinary management strategy is required for PPVS. Despite satisfactory early repair, patients continue to be at risk for recurrence and subsequent mortality, especially those with extensive primary involvement. The disappointing results underscore the need for multi-institutional collaborations to better understand this complex disease, establish management and follow-up protocols, and explore investigational treatment modalities that could modify the unfavorable outcome of this uncommon and challenging disease., (Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
36. Impact of Palliation Strategy on Interstage Feeding and Somatic Growth for Infants With Ductal-Dependent Pulmonary Blood Flow: Results from the Congenital Catheterization Research Collaborative.
- Author
-
Nicholson GT, Glatz AC, Qureshi AM, Petit CJ, Meadows JJ, McCracken C, Kelleman M, Bauser-Heaton H, Gartenberg AJ, Ligon RA, Aggarwal V, Kwakye DB, and Goldstein BH
- Subjects
- Age Factors, Body Height, Child, Preschool, Ductus Arteriosus diagnostic imaging, Female, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital physiopathology, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, Stents, Time Factors, Treatment Outcome, United States, Weight Gain, Blalock-Taussig Procedure adverse effects, Cardiac Catheterization adverse effects, Cardiac Catheterization instrumentation, Child Development, Ductus Arteriosus physiopathology, Feeding Methods adverse effects, Heart Defects, Congenital surgery, Palliative Care, Pulmonary Circulation
- Abstract
Background In infants with ductal-dependent pulmonary blood flow, the impact of palliation strategy on interstage growth and feeding regimen is unknown. Methods and Results This was a retrospective multicenter study of infants with ductal-dependent pulmonary blood flow palliated with patent ductus arteriosus (PDA) stent or Blalock-Taussig shunt (BTS) from 2008 to 2015. Subjects with a defined interstage, the time between initial palliation and subsequent palliation or repair, were included. Primary outcome was change in weight-for-age Z -score. Secondary outcomes included % of patients on: all oral feeds, feeding-related medications, higher calorie feeds, and feeding-related readmission. Propensity score was used to account for baseline differences. Subgroup analysis was performed in 1- (1V) and 2-ventricle (2V) groups. The cohort included 66 PDA stent (43.9% 1V) and 195 BTS (54.4% 1V) subjects. Prematurity was more common in the PDA stent group ( P =0.051). After adjustment, change in weight-for-age Z -score did not differ between groups over the entire interstage. However, change in weight-for-age Z -score favored PDA stent during the inpatient interstage ( P =0.005) and BTS during the outpatient interstage ( P =0.032). At initial hospital discharge, PDA stent treatment was associated with all oral feeds ( P <0.001) and absence of feeding-related medications ( P =0.002). Subgroup analysis revealed that 2V but not 1V patients demonstrated significant increase in weight-for-age Z -score. In the 2V cohort, feeding-related readmissions were more common in the BTS group ( P =0.008). Conclusions In infants with ductal-dependent pulmonary blood flow who underwent palliation with PDA stent or BTS, there was no difference in interstage growth. PDA stent was associated with a simpler feeding regimen and fewer feeding-related readmissions.
- Published
- 2020
- Full Text
- View/download PDF
37. Patient-Specific 3-Dimensional-Bioprinted Model for In Vitro Analysis and Treatment Planning of Pulmonary Artery Atresia in Tetralogy of Fallot and Major Aortopulmonary Collateral Arteries.
- Author
-
Tomov ML, Cetnar A, Do K, Bauser-Heaton H, and Serpooshan V
- Subjects
- Aorta, Thoracic surgery, Humans, Neovascularization, Pathologic surgery, Patient Care Planning, Pulmonary Artery surgery, Aorta, Thoracic abnormalities, Bioprinting, Models, Anatomic, Neovascularization, Pathologic pathology, Printing, Three-Dimensional, Pulmonary Artery abnormalities, Tetralogy of Fallot complications
- Abstract
Background Tetralogy of Fallot with major aortopulmonary collateral arteries is a heterogeneous form of pulmonary artery (PA) stenosis that requires multiple forms of intervention. We present a patient-specific in vitro platform capable of sustained flow that can be used to train proceduralists and surgical teams in current interventions, as well as in developing novel therapeutic approaches to treat various vascular anomalies. Our objective is to develop an in vitro model of PA stenosis based on patient data that can be used as an in vitro phantom to model cardiovascular disease and explore potential interventions. Methods and Results From patient-specific scans obtained via computer tomography or 3-dimensional (3D) rotational angiography, we generated digital 3D models of the arteries. Subsequently, in vitro models of tetralogy of Fallot with major aortopulmonary collateral arteries were first 3D printed using biocompatible resins and next bioprinted using gelatin methacrylate hydrogel to simulate neonatal vasculature or second-order branches of an older patient with tetralogy of Fallot with major aortopulmonary collateral arteries. Printed models were used to study creation of extraluminal connection between an atretic PA and a major aortopulmonary collateral artery using a catheter-based interventional method. Following the recanalization, engineered PA constructs were perfused and flow was visualized using contrast agents and x-ray angiography. Further, computational fluid dynamics modeling was used to analyze flow in the recanalized model. Conclusions New 3D-printed and computational fluid dynamics models for vascular atresia were successfully created. We demonstrated the unique capability of a printed model to develop a novel technique for establishing blood flow in atretic vessels using clinical imaging, together with 3D bioprinting-based tissue engineering techniques. Additive biomanufacturing technologies can enable fabrication of functional vascular phantoms to model PA stenosis conditions that can help develop novel clinical applications.
- Published
- 2019
- Full Text
- View/download PDF
38. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.
- Author
-
Hajipour MJ, Mehrani M, Abbasi SH, Amin A, Kassaian SE, Garbern JC, Caracciolo G, Zanganeh S, Chitsazan M, Aghaverdi H, Kamali Shahri SM, Ashkarran A, Raoufi M, Bauser-Heaton H, Zhang J, Muehlschlegel JD, Moore A, Lee RT, Wu JC, Serpooshan V, and Mahmoudi M
- Subjects
- Animals, Heart Failure prevention & control, Humans, Heart Failure therapy, Nanomedicine methods, Regenerative Medicine methods
- Abstract
The adult myocardium has a limited regenerative capacity following heart injury, and the lost cells are primarily replaced by fibrotic scar tissue. Suboptimal efficiency of current clinical therapies to resurrect the infarcted heart results in injured heart enlargement and remodeling to maintain its physiological functions. These remodeling processes ultimately leads to ischemic cardiomyopathy and heart failure (HF). Recent therapeutic approaches (e.g., regenerative and nanomedicine) have shown promise to prevent HF postmyocardial infarction in animal models. However, these preclinical, clinical, and technological advancements have yet to yield substantial enhancements in the survival rate and quality of life of patients with severe ischemic injuries. This could be attributed largely to the considerable gap in knowledge between clinicians and nanobioengineers. Development of highly effective cardiac regenerative therapies requires connecting and coordinating multiple fields, including cardiology, cellular and molecular biology, biochemistry and chemistry, and mechanical and materials sciences, among others. This review is particularly intended to bridge the knowledge gap between cardiologists and regenerative nanomedicine experts. Establishing this multidisciplinary knowledge base may help pave the way for developing novel, safer, and more effective approaches that will enable the medical community to reduce morbidity and mortality in HF patients.
- Published
- 2019
- Full Text
- View/download PDF
39. Comparison of Outcomes at Time of Superior Cavopulmonary Connection Between Single Ventricle Patients With Ductal-Dependent Pulmonary Blood Flow Initially Palliated With Either Blalock-Taussig Shunt or Ductus Arteriosus Stent: Results From the Congenital Catheterization Research Collaborative.
- Author
-
Meadows JJ, Qureshi AM, Goldstein BH, Petit CJ, McCracken CE, Kelleman MS, Aggarwal V, Bauser-Heaton H, Combs CS, Gartenberg AJ, Ligon RA, Nicholson GT, and Glatz AC
- Subjects
- Cardiac Catheterization adverse effects, Cardiac Catheterization mortality, Coronary Circulation, Ductus Arteriosus diagnostic imaging, Female, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital mortality, Heart Defects, Congenital physiopathology, Heart Ventricles diagnostic imaging, Heart Ventricles physiopathology, Hemodynamics, Humans, Infant, Newborn, Male, Pulmonary Artery diagnostic imaging, Pulmonary Artery physiopathology, Pulmonary Circulation, Recovery of Function, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, United States, Blalock-Taussig Procedure adverse effects, Blalock-Taussig Procedure mortality, Cardiac Catheterization instrumentation, Ductus Arteriosus physiopathology, Heart Defects, Congenital surgery, Heart Ventricles surgery, Palliative Care, Pulmonary Artery surgery, Stents
- Abstract
Background: Patients with single ventricle anatomy and ductal-dependent pulmonary blood flow may be initially palliated with either modified Blalock-Taussig shunt (BTS) or ductus arteriosus stent (DAS). Comparisons of outcomes during the interstage period and at the time of superior cavopulmonary connection (SCPC) are lacking and may differ between palliation strategies., Methods: Infants with single ventricle anatomy and ductal-dependent pulmonary blood flow palliated with either DAS or BTS from 2008 to 2015 were reviewed across 4 centers. Interstage outcomes, and for those who had SCPC, anatomy, hemodynamics, and perioperative clinical outcomes were compared. Thirty-five patients with DAS and 136 patients with BTS were included., Results: At initial palliation, demographic, clinical variables, and pulmonary artery size were similar. Interstage death, transplant, or unplanned reintervention to treat cyanosis occurred in 25.7% of DAS and 35.8% of BTS, P =0.27. Reintervention was more common with DAS (48.6% versus 2.2%; P <0.001). Twenty-three DAS patients and 111 BTS patients underwent SCPC. Preoperative hemodynamics and overall pulmonary atresia growth were similar, although right pulmonary artery growth was better with DAS (change in z -score: 1.57 versus 0.65, P =0.026). SCPC intraoperative and postoperative courses were similar., Conclusions: In patients with single-ventricle anatomy and ductal-dependent pulmonary blood flow, interstage outcomes, hemodynamics before SCPC, and acute postoperative outcomes were similar. Overall reintervention was more common in the DAS group, driven by more frequent planned reintervention. Unplanned reintervention, death, and transplant were similar. Both groups demonstrated good pulmonary atresia growth. DAS is a reasonable initial palliative alternative to BTS in select patients.
- Published
- 2019
- Full Text
- View/download PDF
40. Outcomes After Aortopulmonary Window for Hypoplastic Pulmonary Arteries and Dual-Supply Collaterals.
- Author
-
Bauser-Heaton H, Ma M, McElhinney DB, Goodyer WR, Zhang Y, Chan FP, Asija R, Shek J, Wise-Faberowski L, and Hanley FL
- Subjects
- Abnormalities, Multiple diagnostic imaging, Abnormalities, Multiple surgery, Aortopulmonary Septal Defect diagnostic imaging, Aortopulmonary Septal Defect surgery, Cohort Studies, Collateral Circulation physiology, Databases, Factual, Female, Follow-Up Studies, Hospitals, Pediatric, Humans, Infant, Newborn, Male, Pulmonary Atresia diagnostic imaging, Pulmonary Atresia mortality, Retrospective Studies, Risk Assessment, Survival Analysis, Tetralogy of Fallot diagnostic imaging, Tetralogy of Fallot mortality, Time Factors, Treatment Outcome, Cardiac Surgical Procedures methods, Computed Tomography Angiography methods, Imaging, Three-Dimensional, Pulmonary Atresia surgery, Tetralogy of Fallot surgery
- Abstract
Background: Our institutional approach to tetralogy of Fallot with major aortopulmonary collateral arteries (MAPCAs) emphasizes early unifocalization and complete repair (CR). In the small subset of patients with dual-supply MAPCAs and confluent but hypoplastic central pulmonary arteries (PAs), our surgical approach is early creation of an aortopulmonary window (APW) to promote PA growth. Factors associated with successful progression to CR and mid-term outcomes have not been assessed., Methods: Clinical data were reviewed. PA diameters were measured offline from angiograms prior to APW and on follow-up catheterization >1 month after APW but prior to any additional surgical interventions., Results: From November 2001 to March 2018, 352 patients with tetralogy of Fallot/MAPCAs underwent initial surgery at our center, 40 of whom had a simple APW with or without ligation of MAPCAs as the first procedure (median age, 1.4 months). All PA diameters increased significantly on follow-up angiography. Ultimately, 35 patients underwent CR after APW. Nine of these patients (26%) underwent intermediate palliative operation between 5 and 39 months (median, 8 months) after APW. There were no early deaths. The cumulative incidence of CR was 65% 1 year post-APW and 87% at 3 years. Repaired patients were followed for a median of 4.2 years after repair; the median PA:aortic pressure ratio was 0.39 (range, 0.22 to 0.74)., Conclusions: Most patients with tetralogy of Fallot/MAPCAs and hypoplastic but normally arborizing PAs and dual-supply MAPCAs are able to undergo CR with low right ventricular pressure after APW early in life. Long-term outcomes were good, with acceptable PA pressures in most patients., (Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
41. Use of Novel "Flip Technique" Aids in Percutaneous Carotid Artery Approach in Neonates.
- Author
-
Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC, and Petit CJ
- Subjects
- Ductus Arteriosus, Patent diagnostic imaging, Ductus Arteriosus, Patent physiopathology, Humans, Infant, Newborn, Punctures, Treatment Outcome, Cardiac Catheterization instrumentation, Carotid Artery, Common, Catheterization, Peripheral, Ductus Arteriosus, Patent therapy, Patient Positioning, Stents
- Published
- 2019
- Full Text
- View/download PDF
42. Outcomes After Initial Unifocalization to a Shunt in Complex Tetralogy of Fallot With MAPCAs.
- Author
-
Bauser-Heaton H, Ma M, Wise-Faberowski L, Asija R, Shek J, Zhang Y, Peng LF, Sidell DR, Hanley FL, and McElhinney DB
- Subjects
- Adolescent, Cardiac Surgical Procedures methods, Child, Child, Preschool, Collateral Circulation, Female, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, Tetralogy of Fallot complications, Treatment Outcome, Vascular Surgical Procedures methods, Abnormalities, Multiple surgery, Aorta, Thoracic abnormalities, Aorta, Thoracic surgery, Pulmonary Artery abnormalities, Pulmonary Artery surgery, Tetralogy of Fallot surgery
- Abstract
Background: Our approach to tetralogy of Fallot (TOF) with pulmonary atresia and major aortopulmonary collateral arteries (MAPCAs) emphasizes early single-stage unifocalization and intracardiac repair. However, a subset of patients with small native pulmonary arteries (PAs) and MAPCAs undergo unifocalization to a shunt rather than simultaneous intracardiac repair., Methods: Patients with TOF/MAPCAs who underwent complete unifocalization to a systemic-to-PA shunt by a single surgeon were reviewed. The decision to perform simultaneous intracardiac repair was based on an intraoperative flow study or empirical assessment of PA and MAPCA size., Results: From November 2001 to December 2017, 57 patients with TOF/MAPCAs underwent unifocalization to a shunt at a median age of 6.9 months. Genetic abnormalities were documented in 60% of patients, including a chromosome 22q11 deletion in 25 and Alagille syndrome in 8. Twenty patients (35%) had undergone prior surgery elsewhere (n = 16) and/or at our center (n = 7). During a median follow-up of 5.4 years, 9 patients had additional surgery to revise the PA reconstruction before complete repair, and 38 patients underwent complete repair. Five years after unifocalization, survival was 74% ± 6%. At follow-up, the median PA to aortic systolic pressure ratio was 0.36 and was greater than 0.50 in 2 patients., Conclusions: In patients with the smallest MAPCAs and PAs, single-stage unifocalization to a shunt followed by intracardiac repair yields an excellent outcome in most cases., (Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
43. Assessment of the Reconstructed Pulmonary Circulation With Lung Perfusion Scintigraphy After Unifocalization and Repair of Tetralogy of Fallot With Major Aortopulmonary Collaterals.
- Author
-
Wise-Faberowski L, Irvin M, Lennig M, Long J, Nadel HR, Bauser-Heaton H, Asija R, Hanley FL, and McElhinney DB
- Subjects
- Aged, Aorta, Thoracic diagnostic imaging, Child, Preschool, Female, Humans, Infant, Male, Pulmonary Artery diagnostic imaging, Tetralogy of Fallot diagnosis, Tetralogy of Fallot physiopathology, Aorta, Thoracic surgery, Cardiac Surgical Procedures methods, Collateral Circulation physiology, Pulmonary Artery surgery, Pulmonary Circulation physiology, Tetralogy of Fallot surgery, Ventilation-Perfusion Scan methods
- Abstract
Background: Pulmonary vascular supply in tetralogy of Fallot (TOF) with major aortopulmonary collaterals (MAPCAs) is highly variable. Our approach to surgical management of this condition emphasizes early repair including unifocalization and reconstruction of the pulmonary circulation, incorporating all lung segments and addressing stenoses both proximal to and within the lung, in addition to ventricular septal defect closure. At our institution, we have over 15 years of experience using lung perfusion scintigraphy (LPS) to assess the distribution of pulmonary blood flow after complete unifocalization and repair., Methods: We reviewed clinical and quantitative LPS data in 310 patients who underwent complete unifocalization and repair of TOF/MAPCAs from 2003 to 2018 at our institution. Postrepair relative lung perfusion distributions were determined from LPS initially obtained at our institution within 60 days after repair and thereafter., Results: Total lung perfusion to the right and left lungs was 58.0% ± 14.2% and 42.0% ± 14.2%, respectively. Perfusion was balanced in 75% of patients and unbalanced in 25%, including 11% in whom it was extremely unbalanced. On multivariable analysis, older age at repair, surgery other than a single-stage complete unifocalization, and native anatomy consisting of unilateral pulmonary blood supply through a ductus arteriosus were associated with unbalanced perfusion., Conclusion: We present our experience using LPS as an outcome measure after surgical repair of TOF/MAPCAs. Balanced lung perfusion was present in the majority of patients who had complete repair of TOF/MAPCAs performed at our center.
- Published
- 2019
- Full Text
- View/download PDF
44. Repair of Untreated Older Patients With Tetralogy of Fallot With Major Aortopulmonary Collaterals.
- Author
-
Vaikunth SS, Bauser-Heaton H, Lui GK, Wise-Faberowski L, Chan FP, Asija R, Hanley FL, and McElhinney DB
- Subjects
- Adult, Age Factors, Cardiac Surgical Procedures mortality, Child, Preschool, Cohort Studies, Female, Humans, Infant, Kaplan-Meier Estimate, Male, Patient Safety, Prognosis, Retrospective Studies, Risk Assessment, Survival Rate, Tetralogy of Fallot diagnostic imaging, Tetralogy of Fallot mortality, Treatment Outcome, Young Adult, Cardiac Surgical Procedures methods, Collateral Circulation physiology, Pulmonary Circulation physiology, Tetralogy of Fallot surgery
- Abstract
Background: Our programmatic approach to tetralogy of Fallot with major aortopulmonary collaterals emphasizes single-stage unifocalization with complete intracardiac repair during infancy. Little is known about suitability for complete repair in patients beyond infancy. We sought to analyze outcomes of our approach in older patients with previously untreated tetralogy of Fallot with major aortopulmonary collaterals., Methods: Any patient with this lesion not treated before 2 years of age referred to our center from 2002 to 2017 met inclusion criteria., Results: Of 33 patients, 32 were out-of-state (64% international) referrals, and 33% (n = 11) were older than 9 years, had polycythemia, or at least 1 high pressure collateral (>25 mm Hg). Complete repair was achieved in 94% (n = 31) of patients, 82% (n = 27) in one stage and 12% (n = 4) after unifocalization to a central shunt. The median right ventricular-to-aortic pressure ratio was 0.31 after the operation and 0.37 at follow-up. At a median of 4.8 years after repair, 9 patients (19%) underwent reintervention, including 5 conduit and 7 branch pulmonary artery interventions. Three patients also underwent aortic valve replacement., Conclusions: In this selected cohort of older patients with previously unoperated tetralogy of Fallot with major aortopulmonary collaterals, outcomes were comparable with infants undergoing treatment according to our approach. These findings support the notion that patients who are either born in low-resource settings or present to health care providers beyond infancy should be considered candidates and evaluated for complete repair., (Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
45. Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery - CORRIGENDUM.
- Author
-
Koth A, Sidell D, Bauser-Heaton H, Wise-Faberowski L, Hanley FL, McElhinney DB, and Asija R
- Published
- 2019
- Full Text
- View/download PDF
46. Association of dead space ventilation and prolonged ventilation after repair of tetralogy of Fallot with pulmonary atresia.
- Author
-
Koth AM, Kwiatkowski DM, Lim TR, Bauser-Heaton H, Asija R, McElhinney DB, Hanley FL, and Krawczeski CD
- Subjects
- Adolescent, Age Factors, Child, Child, Preschool, Female, Humans, Male, Risk Factors, Sex Factors, Tetralogy of Fallot complications, Time Factors, Pulmonary Atresia complications, Respiration, Artificial adverse effects, Respiratory Dead Space, Tetralogy of Fallot surgery
- Abstract
Background: We set out to determine whether patients with tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries (TOF/PA/MAPCA) are at risk for elevated dead space ventilation fraction (VD/VT), and whether this is associated with prolonged mechanical ventilation. We hypothesized that elevated VD/VT (>20%) in the first 24 hours after unifocalization surgery is associated with increased risk for prolonged mechanical ventilation (>7 days)., Methods: All patients with TOF/PA/MAPCA undergoing unifocalization surgery between January 2003 and December 2015 were included in this study. Average VD/VT was calculated over the first 24 hours after surgery. Demographic and surgical data were collected. Outcome data included duration of mechanical ventilation. Patients were separated into 2 groups: elevated VD/VT and normal DVSF. Groups were compared using the Student t test, Wilcoxon rank-sum test, and χ
2 test. Univariable and multivariable regression analyses were performed with VD/VT as a continuous variable to test for association., Results: Of the 265 included patients, 127 (48%) had an elevated VD/VT. The 2 groups did not differ significantly in any demographic characteristic. Patients with an elevated VD/VT had longer cardiopulmonary bypass times (P = .03), were more likely to have delayed sternal closure, and more likely to have prolonged respiratory failure (odds ratio, 2.2; 95% confidence interval, 1.2-4.0; P = .007). The percent VD/VT was associated with duration of mechanical ventilation in univariable (P < .001) and multivariable (P < .001) regression analyses when controlled for age, weight and bypass time., Conclusions: Elevated postoperative VD/VT is associated with prolonged mechanical ventilation in patients with TOF/PA/MAPCA following unifocalization. Elevated postoperative VD/VT may be an early indicator of patients who will require prolonged duration of mechanical ventilation, allowing optimization of medical management to promote better outcomes., (Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
47. Pulmonary reinterventions after complete unifocalization and repair in infants and young children with tetralogy of Fallot with major aortopulmonary collaterals.
- Author
-
Bauser-Heaton H, Borquez A, Asija R, Wise-Faberowski L, Zhang Y, Downey L, Perry SB, Koth A, Peng LF, Algaze CA, Hanley FL, and McElhinney DB
- Subjects
- Aorta diagnostic imaging, Aorta physiopathology, Cardiac Surgical Procedures mortality, Female, Heart Valve Prosthesis, Humans, Infant, Male, Postoperative Complications diagnostic imaging, Postoperative Complications mortality, Postoperative Complications physiopathology, Pulmonary Artery diagnostic imaging, Pulmonary Artery physiopathology, Reoperation, Retrospective Studies, Risk Factors, Stents, Tetralogy of Fallot diagnostic imaging, Tetralogy of Fallot mortality, Tetralogy of Fallot physiopathology, Time Factors, Treatment Outcome, Ventricular Function, Right, Angioplasty adverse effects, Angioplasty instrumentation, Angioplasty mortality, Aorta surgery, Cardiac Surgical Procedures adverse effects, Collateral Circulation, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation mortality, Postoperative Complications surgery, Pulmonary Artery surgery, Pulmonary Circulation, Tetralogy of Fallot surgery, Vascular Remodeling
- Abstract
Background: Our institutional approach to tetralogy of Fallot (TOF) with major aortopulmonary collaterals (MAPCAs) emphasizes unifocalization and augmentation of the reconstructed pulmonary arterial (PA) circulation and complete intracardiac repair in infancy, usually in a single procedure. This approach yields a high rate of complete repair with excellent survival and low right ventricular (RV) pressure. However, little is known about remodeling of the unifocalized and reconstructed pulmonary circulation or about reinterventions on the reconstructed PAs or the RV outflow tract conduit., Methods: We reviewed patients who underwent complete repair of TOF with MAPCAs at our center at <2 years of age, either as a single-stage procedure or after previous procedures. Outcomes included freedom from conduit or PA intervention after repair, which were assessed by Cox regression and Kaplan-Meier analysis., Results: The study cohort included 272 patients. There were 6 early deaths and a median of follow-up of 3.6 years after complete repair. Reinterventions on the pulmonary circulation were performed in 134 patients, including conduit interventions in 101 patients, branch PA interventions in 101, and closure of residual MAPCAs in 9. The first conduit reintervention consisted of surgical conduit replacement in 77 patients, transcatheter pulmonary valve replacement with a Melody valve in 14, and angioplasty or bare metal stenting in 10. Surgical PA reinterventions were performed in 46 patients and transcatheter reinterventions in 75 (both in 20). Most PA reinterventions involved a single lung, and most transcatheter reinterventions a single vessel. Freedom from conduit replacement or transcatheter pulmonary valve replacement was 70 ± 3% at 5 years and was shorter in patients with smaller initial conduit size. Freedom from any PA reintervention was 64 ± 3% at 5 years, with the greatest rate during the first year. On multivariable analysis, factors associated with longer freedom from any PA reintervention included lower postrepair RV:aortic pressure ratio and larger original conduit size., Conclusions: We were able to obtain follow-up data for the majority of patients, which demonstrated freedom from PA reintervention for two thirds of patients. The time course of and risk factors for conduit reintervention in this cohort appeared similar to previously reported findings in patients who received RV-PA conduits in early childhood for other anomalies. Relative to the severity of baseline pulmonary vascular anatomy in TOF with MAPCAs, reinterventions on the reconstructed PAs were uncommon after repair according to our approach, and major reinterventions were rare. Nevertheless, PA reinterventions are an important aspect of the overall management strategy., (Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
48. Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits.
- Author
-
Shahanavaz S, Qureshi AM, Levi DS, Boudjemline Y, Peng LF, Martin MH, Bauser-Heaton H, Keeshan B, Asnes JD, Jones TK, Justino H, Aboulhosn JA, Gray RG, Nguyen H, Balzer DT, and McElhinney DB
- Subjects
- Adolescent, Adult, Angiography, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation adverse effects, Blood Vessel Prosthesis Implantation instrumentation, Cardiac Catheterization adverse effects, Cardiac Catheterization methods, Child, Child, Preschool, Feasibility Studies, Female, Graft Occlusion, Vascular diagnostic imaging, Graft Occlusion, Vascular etiology, Graft Occlusion, Vascular physiopathology, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation methods, Hemodynamics, Humans, Male, Preliminary Data, Prosthesis Design, Pulmonary Valve diagnostic imaging, Pulmonary Valve physiopathology, Retrospective Studies, Time Factors, Treatment Outcome, United States, Ventricular Outflow Obstruction diagnostic imaging, Ventricular Outflow Obstruction etiology, Ventricular Outflow Obstruction physiopathology, Young Adult, Cardiac Catheterization instrumentation, Graft Occlusion, Vascular surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation instrumentation, Pulmonary Valve surgery, Ventricular Outflow Obstruction surgery
- Abstract
Objectives: This study sought to evaluate the safety, feasibility, and outcomes of transcatheter pulmonary valve replacement (TPVR) in conduits ≤16 mm in diameter., Background: The Melody valve (Medtronic, Minneapolis, Minnesota) is approved for the treatment of dysfunctional right ventricular outflow tract (RVOT) conduits ≥16 mm in diameter at the time of implant. Limited data are available regarding the use of this device in smaller conduits., Methods: The study retrospectively evaluated patients from 9 centers who underwent percutaneous TPVR into a conduit that was ≤16 mm in diameter at the time of implant, and reported procedural characteristics and outcomes., Results: A total of 140 patients were included and 117 patients (78%; median age and weight 11 years of age and 35 kg, respectively) underwent successful TPVR. The median original conduit diameter was 15 (range: 9 to 16) mm, and the median narrowest conduit diameter was 11 (range: 4 to 23) mm. Conduits were enlarged to a median diameter of 19 mm (29% larger than the implanted diameter), with no difference between conduits. There was significant hemodynamic improvement post-implant, with a residual peak RVOT pressure gradient of 7 mm Hg (p < 0.001) and no significant pulmonary regurgitation. During a median follow-up of 2.0 years, freedom from RVOT reintervention was 97% and 89% at 2 and 4 years, respectively, and there were no deaths and 5 cases of endocarditis (incidence rate 2.0% per patient-year)., Conclusions: In this preliminary experience, TPVR with the Melody valve into expandable small diameter conduits was feasible and safe, with favorable early and long-term procedural and hemodynamic outcomes., (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
49. Bronchoscopy in children with tetralogy of fallot, pulmonary atresia, and major aortopulmonary collaterals.
- Author
-
Sidell DR, Koth AM, Bauser-Heaton H, McElhinney DB, Wise-Faberowski L, Tracy MC, Hanley FL, and Asija R
- Subjects
- 22q11 Deletion Syndrome surgery, Abnormalities, Multiple surgery, Adolescent, Adult, Bronchoscopy, Child, Child, Preschool, Collateral Circulation, Female, Hospitalization, Humans, Infant, Infant, Newborn, Intensive Care Units, Male, Pulmonary Atresia surgery, Respiration, Artificial, Respiratory System Abnormalities surgery, Retrospective Studies, Tetralogy of Fallot surgery, Young Adult, 22q11 Deletion Syndrome diagnosis, Abnormalities, Multiple diagnosis, Pulmonary Artery abnormalities, Pulmonary Atresia diagnosis, Respiratory System Abnormalities diagnosis, Tetralogy of Fallot diagnosis
- Abstract
Objective: Children with Tetralogy of Fallot, Pulmonary Atresia, and Major Aortopulmonary Collaterals (TOF/PA/MAPCAs) undergoing unifocalization surgery are at risk for developing more postoperative respiratory complications than children undergoing other types of congenital heart surgery. Bronchoscopy is used in the perioperative period for diagnostic and therapeutic purposes. In this study, we describe bronchoscopic findings and identify factors associated with selection for bronchoscopy., Design: Retrospective case-control., Patients and Methods: All patients with TOF/PA/MAPCAs who underwent unifocalization surgery from September 2005 through March 2016 were included. Patients who underwent bronchoscopy in the perioperative period were compared to a randomly selected cohort of 172 control patients who underwent unifocalization without bronchoscopy during the study period., Results: Forty-three children underwent perioperative bronchoscopy at a median of 9 days postoperatively. Baseline demographics were similar in bronchoscopy patients and controls. Patients who underwent bronchoscopy were more likely to have a chromosome 22q11 deletion and were more likely have undergone unifocalization surgery without intracardiac repair. These patients had a longer duration of mechanical ventilation, ICU duration, and length of hospitalization. Abnormalities were detected on bronchoscopy in 35 patients (81%), and 20 (35%) of bronchoscopy patients underwent a postoperative intervention related to abnormalities identified on bronchoscopy., Conclusion: Bronchoscopy is a useful therapeutic and diagnostic instrument for children undergoing unifocalization surgery, capable of identifying abnormalities leading to an additional intervention in over one third of patients. Special attention should be given to children with a 22q11 deletion to expedite diagnosis and intervention for possible airway complications., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
50. Programmatic Approach to Management of Tetralogy of Fallot With Major Aortopulmonary Collateral Arteries: A 15-Year Experience With 458 Patients.
- Author
-
Bauser-Heaton H, Borquez A, Han B, Ladd M, Asija R, Downey L, Koth A, Algaze CA, Wise-Faberowski L, Perry SB, Shin A, Peng LF, Hanley FL, and McElhinney DB
- Subjects
- Aorta, Thoracic surgery, Child, Child, Preschool, Collateral Circulation, Female, Humans, Infant, Male, Pulmonary Artery surgery, Pulmonary Circulation, Retrospective Studies, Tetralogy of Fallot diagnosis, Tetralogy of Fallot physiopathology, Treatment Outcome, Vascular Malformations diagnosis, Vascular Malformations physiopathology, Aorta, Thoracic abnormalities, Cardiac Surgical Procedures methods, Forecasting, Pulmonary Artery abnormalities, Plastic Surgery Procedures methods, Tetralogy of Fallot surgery, Vascular Malformations surgery
- Abstract
Background: Tetralogy of Fallot with major aortopulmonary collateral arteries is a complex and heterogeneous condition. Our institutional approach to this lesion emphasizes early complete repair with the incorporation of all lung segments and extensive lobar and segmental pulmonary artery reconstruction., Methods and Results: We reviewed all patients who underwent surgical intervention for tetralogy of Fallot and major aortopulmonary collateral arteries at Lucile Packard Children's Hospital Stanford (LPCHS) since November 2001. A total of 458 patients underwent surgery, 291 (64%) of whom underwent their initial procedure at LPCHS. Patients were followed for a median of 2.7 years (mean 4.3 years) after the first LPCHS surgery, with an estimated survival of 85% at 5 years after first surgical intervention. Factors associated with worse survival included first LPCHS surgery type other than complete repair and Alagille syndrome. Of the overall cohort, 402 patients achieved complete unifocalization and repair, either as a single-stage procedure (n=186), after initial palliation at our center (n=74), or after surgery elsewhere followed by repair/revision at LPCHS (n=142). The median right ventricle:aortic pressure ratio after repair was 0.35. Estimated survival after repair was 92.5% at 10 years and was shorter in patients with chromosomal anomalies, older age, a greater number of collaterals unifocalized, and higher postrepair right ventricle pressure., Conclusions: Using an approach that emphasizes early complete unifocalization and repair with incorporation of all pulmonary vascular supply, we have achieved excellent results in patients with both native and previously operated tetralogy of Fallot and major aortopulmonary collateral arteries., (© 2017 American Heart Association, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.